Scientists investigated the use of JAK inhibitors for anti-cancer activity in coloretal cancer cell lines, mouse model organoids and patient-derived organoids.
[Journal Of Experimental & Clinical Cancer Research]
Home Newsletters Intestinal Cell News JAK/STAT3 Represents a Therapeutic Target for Colorectal Cancer Patients with Stromal-Rich Tumors
